D. A. Thomas

Statistics

Publications

Citations

H-Index

Active since

2008

Affiliations

Albert Einstein College of Medicine(Current)

D. A. Thomas is an author at Albert Einstein College of Medicine specializing in oncology, acute lymphoblastic leukemia treatment, and acute lymphoblastic leukemia therapy.

Publications per year

2008–2013

Publications

Phase I/II Trial of Nanomolecular Liposomal Annamycin in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Meir Wetzler, D. A. Thomas, Eunice S. Wang et al. · Clinical Lymphoma Myeloma & Leukemia · 2013 · 45 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Long-term outcome after hyper-CVAD and imatinib (IM) for de novo or minimally treated Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-ALL).

D. A. Thomas, Susan O’Brien, S. Faderl et al. · Journal of Clinical Oncology · 2010 · 39 citations

Medicine, Oncology, Pharmacotherapy +14

Outcome after frontline therapy with the hyper-CVAD and imatinib mesylate regimen for adults with <i>de novo</i> or minimally treated Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL)

D. A. Thomas, Hagop M. Kantarjian, Jörge E. Cortes et al. · Journal of Clinical Oncology · 2008 · 12 citations

Medicine, Hematology, Oncology +15

1–3 of 3